Bristol-Myers Squibb Stock Forward View

CELG-RI Stock   0.11  0.01  10.00%   
Bristol-Myers Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Bristol-Myers Squibb's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 18th of February 2026, the value of RSI of Bristol-Myers Squibb's share price is approaching 38 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bristol-Myers Squibb, making its price go up or down.

Momentum 38

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of Bristol-Myers Squibb's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Bristol Myers Squibb, which may create opportunities for some arbitrage if properly timed.
Using Bristol-Myers Squibb hype-based prediction, you can estimate the value of Bristol Myers Squibb from the perspective of Bristol-Myers Squibb response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Bristol Myers Squibb on the next trading day is expected to be 0.16 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.07.

Bristol-Myers Squibb after-hype prediction price

    
  USD 0.1  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out fundamental analysis of Bristol-Myers Squibb to check your projections.
For more detail on how to invest in Bristol-Myers Stock please use our How to Invest in Bristol-Myers Squibb guide.

Bristol-Myers Squibb Additional Predictive Modules

Most predictive techniques to examine Bristol-Myers price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bristol-Myers using various technical indicators. When you analyze Bristol-Myers charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for Bristol-Myers Squibb is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Bristol Myers Squibb value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Bristol-Myers Squibb Naive Prediction Price Forecast For the 19th of February

Given 90 days horizon, the Naive Prediction forecasted value of Bristol Myers Squibb on the next trading day is expected to be 0.16 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0005, and the sum of the absolute errors of 1.07.
Please note that although there have been many attempts to predict Bristol-Myers Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bristol-Myers Squibb's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Bristol-Myers Squibb Stock Forecast Pattern

Bristol-Myers Squibb Forecasted Value

In the context of forecasting Bristol-Myers Squibb's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bristol-Myers Squibb's downside and upside margins for the forecasting period are 0 and 21.09, respectively. We have considered Bristol-Myers Squibb's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.11
0.16
Expected Value
21.09
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Bristol-Myers Squibb stock data series using in forecasting. Note that when a statistical model is used to represent Bristol-Myers Squibb stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria110.5275
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0175
MAPEMean absolute percentage error0.2548
SAESum of the absolute errors1.0655
This model is not at all useful as a medium-long range forecasting tool of Bristol Myers Squibb. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Bristol-Myers Squibb. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Bristol-Myers Squibb

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bristol Myers Squibb. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.010.1021.03
Details
Intrinsic
Valuation
LowRealHigh
0.000.0821.01
Details

Bristol-Myers Squibb Estimiated After-Hype Price Volatility

As far as predicting the price of Bristol-Myers Squibb at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bristol-Myers Squibb or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bristol-Myers Squibb, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Bristol-Myers Squibb Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Bristol-Myers Squibb is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bristol-Myers Squibb backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bristol-Myers Squibb, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  4.21 
20.93
 0.00  
  4.00 
10 Events / Month
5 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.11
0.10
0.00 
0.00  
Notes

Bristol-Myers Squibb Hype Timeline

Bristol Myers Squibb is currently traded for 0.11. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -4.0. Bristol-Myers is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 4.21%. %. The volatility of related hype on Bristol-Myers Squibb is about 2200.26%, with the expected price after the next announcement by competition of -3.89. The company last dividend was issued on the 11th of March 2024. Assuming the 90 days trading horizon the next forecasted press release will be in about 10 days.
Check out fundamental analysis of Bristol-Myers Squibb to check your projections.
For more detail on how to invest in Bristol-Myers Stock please use our How to Invest in Bristol-Myers Squibb guide.

Bristol-Myers Squibb Related Hype Analysis

Having access to credible news sources related to Bristol-Myers Squibb's direct competition is more important than ever and may enhance your ability to predict Bristol-Myers Squibb's future price movements. Getting to know how Bristol-Myers Squibb's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bristol-Myers Squibb may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
NVDANVIDIA(5.90)6 per month 0.00 (0.05) 2.95 (3.41) 10.08 
AAPLApple Inc 1.00 5 per month 0.00 (0.08) 2.60 (1.84) 9.06 
GOOGAlphabet Inc Class C(4.22)6 per month 1.38  0.01  2.82 (2.48) 9.42 
MSFTMicrosoft 3.19 5 per month 0.00 (0.21) 1.90 (2.74) 13.28 
AMZNAmazon Inc 7.62 6 per month 0.00 (0.20) 2.53 (3.40) 8.93 
BMYMPBristol Myers Squibb 0.00 0 per month 1.40  0.12  4.04 (1.27) 13.48 
TSMTaiwan Semiconductor Manufacturing(2.42)7 per month 1.72  0.15  3.48 (2.98) 9.62 
METAMeta Platforms(6.88)8 per month 1.52 (0.0001) 3.43 (2.82) 13.69 

Other Forecasting Options for Bristol-Myers Squibb

For every potential investor in Bristol-Myers, whether a beginner or expert, Bristol-Myers Squibb's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bristol-Myers Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bristol-Myers. Basic forecasting techniques help filter out the noise by identifying Bristol-Myers Squibb's price trends.

Bristol-Myers Squibb Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bristol-Myers Squibb stock to make a market-neutral strategy. Peer analysis of Bristol-Myers Squibb could also be used in its relative valuation, which is a method of valuing Bristol-Myers Squibb by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Bristol-Myers Squibb Market Strength Events

Market strength indicators help investors to evaluate how Bristol-Myers Squibb stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bristol-Myers Squibb shares will generate the highest return on investment. By undertsting and applying Bristol-Myers Squibb stock market strength indicators, traders can identify Bristol Myers Squibb entry and exit signals to maximize returns.

Bristol-Myers Squibb Risk Indicators

The analysis of Bristol-Myers Squibb's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bristol-Myers Squibb's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bristol-myers stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Bristol-Myers Squibb

The number of cover stories for Bristol-Myers Squibb depends on current market conditions and Bristol-Myers Squibb's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bristol-Myers Squibb is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bristol-Myers Squibb's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
When determining whether Bristol Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol-Myers Squibb's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:
Check out fundamental analysis of Bristol-Myers Squibb to check your projections.
For more detail on how to invest in Bristol-Myers Stock please use our How to Invest in Bristol-Myers Squibb guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
It's important to distinguish between Bristol-Myers Squibb's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bristol-Myers Squibb should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bristol-Myers Squibb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.